An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

A CDC advisory has recommended to ban the use of thimerosal in flu shots despite no evidence that it causes any harm.

For older adults who express more confidence in vaccine safety than younger groups, the past few months have brought welcome ...

Weeks after President Donald Trump took office, multiple government webpages referencing gender and sexual orientation ...

Routine childhood vaccines are now optional in the United States, and government officials, after hastily compiling an immense research registry of autistic people, have added the neurodevelopmental ...

The market’s swift recovery this month comes as investors continue to monitor the whipsaw of global trade negotiations.

Long before chewing gum came in shiny foil wrappers with watermelon flavors and whitening promises, our ancestors were ...

The trial enrolled more than 40,800 adults 50 and older from 11 countries.

Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...